Publications Ngā whakaputanga kōrero

This guideline sets out recommendations, requirements and response actions for the prevention, management, and control of health care-associated infections due to carbapenemase-producing Enterobacteriaceae (CPE) in acute care and residential care facilities in New Zealand.

This report informs the wider health sector and relevant stakeholders’ what work has been completed and progress achieved in the first year of the Antimicrobial action plan towards the five objectives of the Action Plan.

This five-year national action plan addresses the growing problem of antimicrobial resistance. Work under this action plan will be jointly led by the Ministry of Health and the Ministry for Primary Industries.

This publication outlines the evidence and the collective, expert views of stakeholders from across the sectors of animal and human health, food and agriculture on the current antimicrobial resistance (AMR) situation in New Zealand

Implementing Medicines New Zealand is the action plan for Medicines New Zealand - the New Zealand medicines strategy.

The Guidelines for the Control of Multidrug-resistant Organisms in New Zealand are a resource for DHBs to develop own their local guidelines to control Multidrug-resistant organisms (MDROs).

These Guidelines for the Control of Methicillin-resistant Staphyloccus Aureus (MRSA) in New Zealand are for use by individual health and disability care facilities to develop their own MRSA policy.